The Role of Flavonoids in Inhibiting Th17 Responses in Inflammatory Arthritis.
Dimitra KelepouriΑthanasios MavropoulosDimitrios Petros BogdanosLazaros I SakkasPublished in: Journal of immunology research (2018)
Flavonoids have been considered powerful anti-inflammatory agents, and their exact immunomodulatory action as therapeutic agents in autoimmune diseases has started to emerge. Their role in the manipulation of immunoregulation is less understood. Several studies attempted to investigate the role of various flavonoids mainly in experimental models of autoimmune diseases, especially in the context of their potential effect on the increase of regulatory T cells (Tregs) and their ability to stimulate an overexpression of anti-inflammatory cytokines, in particular that of IL-10. The emergence of IL-17, a cytokine largely produced by Th17 cells, as a powerful proinflammatory stimulus which attenuates the induction of Tregs has prompted a series of studies investigating the role of flavonoids on Th17 cells in experimental models as well as human autoimmune diseases. This review thoroughly discusses accumulated data on the role of flavonoids on Th17 in rheumatoid arthritis and experimental autoimmune arthritis.
Keyphrases
- rheumatoid arthritis
- regulatory t cells
- induced apoptosis
- cell cycle arrest
- endothelial cells
- anti inflammatory
- signaling pathway
- dendritic cells
- endoplasmic reticulum stress
- multiple sclerosis
- transcription factor
- disease activity
- case control
- electronic health record
- cell death
- interstitial lung disease
- systemic sclerosis
- induced pluripotent stem cells
- climate change
- drug induced
- ankylosing spondylitis
- pluripotent stem cells